IGF1 and prostate cancer: Antibiotic treatment reduced the production of SCFAs by the gut microbiota, whereas exogenous administration of SCFAs was found to promote prostate cancer progression through elevation of insulin-like growth factor 1 (IGF-1) levels (Matsushita et al., 2021).